CCKBR and neoplasm: Finally, it is also possible that proglumide could block CCK2R signaling in both tumor and stromal compartments and that tumor cell CCK2R signaling potentially impacts the relative abundance of tumor-suppressive versus tumor-promoting CAF subpopulations within the stroma.